Jefferies Group’s Athenahealth, Inc. ATHN Stock Holding History

Jefferies Group’s Portfolio ATHN Stock Details ATHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,800	Closed	-$3.27M	–	2846
2018 Q4	$3.27M	Sell	24,800 -165,800	-87%	-$21.2M	0.03%	597
2018 Q3	$25.5M	Buy	+190,600	New	+$28.6M	0.17%	98
2017 Q1	–	Sell	-400	Closed	-$42K	–	2805
2016 Q4	$42K	Buy	+400	New	+$43K	﹤0.01%	2094
2016 Q2	–	Sell	-4,900	Closed	-$680K	–	2591
2016 Q1	$680K	Buy	+4,900	New	+$672K	﹤0.01%	1304
2014 Q3	–	Sell	-4,000	Closed	-$501K	–	2587
2014 Q2	$501K	Buy	+4,000	New	+$517K	﹤0.01%	1237

Jefferies Group's ATHN Position: Q1 2019 in Review

Jefferies Group sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 72,292 shares — an estimated $9.54M sold.

Jefferies Group first reported a position in ATHN in Q1 2014 and held it in 13 quarters. The position peaked at $9.54M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.

Jefferies Group reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
Jefferies Group sold 72,292 Athenahealth, Inc. shares in Q1 2019, an estimated $9.54M.
Jefferies Group first reported a position in Athenahealth, Inc. in Q1 2014 and held it in 13 quarters.
Jefferies Group's Athenahealth, Inc. position peaked at $9.54M in Q4 2018.
0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.